Giuseppe
Emeritus
[Source: Ifeng, full page in Chinese: (LINK). Automatic translation.]
H7N9, Taiwan to start Birdflu vaccine animal trials
At 10:08 on September 3, 2013 Source: China News Network
BEIJING, Sept. 3, according to Taiwan's "Central News Agency" reports, "Guoguang" biotechnology and Taipei Veterans General Hospital research team obtained jointly by the Taiwan authorities, Health and Welfare Department grants 34.5 million yuan (NT, the same below), will jointly develop H7N9 vaccine, is expected before the end of next year to obtain the drug card market.
"National Light" Biotech said that although adverse H7N9 virus summer climate, but in July Hebei still appear H7N9 avian influenza diagnosed patients; continent's research team found that, H7N9 virus invades the human body can mutate may borrow through the respiratory tract spread by droplets, the presence of interpersonal pandemic risk.
August 6th, Jiangsu Center for Disease Control and Prevention, "British Medical Journal" published report confirms, H7N9 cases in interpersonal communication limitations have emerged, showing poultry and isolated from human H7N9 virus genome highly homologous, and viruses have a combination of people the ability of airway epithelial cell receptor, suggesting that there will be future virus spread rapidly among people as possible.
"National Light" biotechnology, "said Guoguang" developed in cooperation with the Taipei Veterans General Hospital on August H7N9 vaccine into the animal experiments, is expected next year in January into the first two clinical trials before the end of next year to obtain the drug card and listing for Taiwanese injections.
To prevent the outbreak of a pandemic H7N9 winter, "National Light" biotech said it would with the "Ministry of Health and Welfare 'policy, if needed, could be the first time mass production, and Taiwan for the Taiwanese health prevention checks.
Legal persons that benefit from influenza vaccine made drug card, which helped the "National Light" next year to enhance the capacity utilization rate from the current 3 percent increase to 5 percent, have the opportunity to inject a turnaround next year.
-
-------
H7N9, Taiwan to start Birdflu vaccine animal trials
At 10:08 on September 3, 2013 Source: China News Network
BEIJING, Sept. 3, according to Taiwan's "Central News Agency" reports, "Guoguang" biotechnology and Taipei Veterans General Hospital research team obtained jointly by the Taiwan authorities, Health and Welfare Department grants 34.5 million yuan (NT, the same below), will jointly develop H7N9 vaccine, is expected before the end of next year to obtain the drug card market.
"National Light" Biotech said that although adverse H7N9 virus summer climate, but in July Hebei still appear H7N9 avian influenza diagnosed patients; continent's research team found that, H7N9 virus invades the human body can mutate may borrow through the respiratory tract spread by droplets, the presence of interpersonal pandemic risk.
August 6th, Jiangsu Center for Disease Control and Prevention, "British Medical Journal" published report confirms, H7N9 cases in interpersonal communication limitations have emerged, showing poultry and isolated from human H7N9 virus genome highly homologous, and viruses have a combination of people the ability of airway epithelial cell receptor, suggesting that there will be future virus spread rapidly among people as possible.
"National Light" biotechnology, "said Guoguang" developed in cooperation with the Taipei Veterans General Hospital on August H7N9 vaccine into the animal experiments, is expected next year in January into the first two clinical trials before the end of next year to obtain the drug card and listing for Taiwanese injections.
To prevent the outbreak of a pandemic H7N9 winter, "National Light" biotech said it would with the "Ministry of Health and Welfare 'policy, if needed, could be the first time mass production, and Taiwan for the Taiwanese health prevention checks.
Legal persons that benefit from influenza vaccine made drug card, which helped the "National Light" next year to enhance the capacity utilization rate from the current 3 percent increase to 5 percent, have the opportunity to inject a turnaround next year.
-
-------